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was greater. Similar results have since been
reported from the randomized prospective
trial by Desai and colleagues.2
Second, Mussa and colleagues probably
agree that the ultimate goal of optimizing
graft patency is improving survival. In
well-matched patients undergoing CABG,
all of whom received left ITA to left ante-
rior descending coronary artery pedicle
(LITA-LAD) grafts, using the radial artery
as a second arterial conduit as opposed to
vein resulted in improved late survival, es-
pecially after the third postoperative year
(Figure 1).3 This benefit is similar to or
better than what has been reported with
bilateral ITA grafting. We suggest that the
radial artery is indeed the arterial conduit
of second choice, at least in patients in
whom the bilateral ITA is contraindicated.
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Reply to the Editor:
We thank Zacharias and colleagues for their
interest in our article concerning current per-
spectives in radial artery (RA) use as coro-
nary bypass conduits.1 Their letter raises 2
important issues: (1) comparative patency of
RA versus saphenous vein graft conduits and
(2) the effect of using RA grafts on survival
after coronary bypass surgery.
Concerning the issue of RA versus saphe-
nous vein graft patency, the excellent mid-
term graft patency rates taken from the symp-
tomatic subgroup reported by Zacharias and
colleagues2 merely give an indication of graft
durability but do not provide definitive infor-
mation with respect to long-term patency.
We are fortunate that prospective, random-
ized controlled trials specifically are currently
addressing this question. Recently, Desai and
associates3 reported data from the largest of
these trials, the Radial Artery Patency Study
(RAPS), and found a significant difference in
favor of RA angiographic patency 1 year
after the operation. Buxton’s group has re-
ported results from a much smaller cohort,
part of the Radial Artery Patency and Clinical
Outcome (RAPCO) trial,4 suggesting no sig-
nificant difference in angiographic patency
between RA and saphenous vein grafts.
Forthcoming midterm and long-term patency
data from these groups should resolve this
important issue.
The effect of RA grafts on survival after
CABG has yet to be elucidated in the con-
text of a controlled trial to address the
second point. The 8-year time-to-event
analysis of propensity-matched groups
from Zacharias and colleagues2 provides
encouraging preliminary support for the
thesis that RA conduits might translate to
improved clinical outcomes. Again, a de-
finitive answer awaits analysis of long-term
clinical outcome data from the ongoing
randomized trials.4
The best evidence to date, both in terms
of conduit patency5 and survival,6 suggests
that the optimal strategy for CABG in most
cases is the use of bilateral internal thoracic
arteries. The RA, if used in optimal fash-
ion, is probably the conduit of choice if a
third graft is required or if bilateral internal
thoracic artery grafting is contraindicated.
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Letter to the Editor
Atrial fibrillation: Isolation or
ablation?
To the Editor:
The article “Map-Guided Surgery for Atrial
Fibrillation” by Nitta and associates1 con-
firms and raises important issues. An ade-
quately performed pulmonary vein isola-
tion (PVI) cures most patients with
intermittent atrial fibrillation (AF) but fails
as an isolation procedure in patients with
non–pulmonary vein (non-PV) foci and in
those with continuous AF, in whom the
PVs and the circuits they harbor become
irrelevant to the maintenance of AF. In
these patients the goal shifts from isolating
the trigger to ablating the macroreentrant
circuits. Although a left atrial (LA) proce-
dure is mandatory, the real question is the
following: When do we address the right
atrium (RA)?
The identification of the transition from
intermittent to continuous AF is crucial in
determining the pattern of activation and
the procedure needed. What was the rela-
tionship between the activation pattern and
(1) the underlying structural heart disease
and (2) the pattern (continuous or intermit-
tent) and duration of AF?
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